https://www.prnewswire.com/apac/news-releases/a-random-placebo-controlled-clinical-trial-by-cu-medicine-shows-that-modulation-of-gut-microbiome-using-oral-microencapsulated-live-bacteria-sim01-improves-long-covid-symptoms-301830559.html
/PRNewswire/ -- 70% of patients in Hong Kong who have recovered from COVID-19 continue to suffer from at least one long COVID symptoms at around 6 months....
controlled clinical trialcu medicinerandomplaceboshows